Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.
about
Plakoglobin: role in tumorigenesis and metastasisDifferential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobinOverexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancerSuprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation.Wnt/beta-catenin signaling and small molecule inhibitorsNr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesisDifferential nuclear translocation and transactivation potential of beta-catenin and plakoglobinCharacterization of the gene encoding pinin/DRS/memA and evidence for its potential tumor suppressor functionDifferential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome systemAxin directly interacts with plakoglobin and regulates its stabilityElevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-cateninH-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancerGenome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactionsThe dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction.Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma.Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms.E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.Cadherin and catenin alterations in human cancer.A possible role for the WNT-1 pathway in oral carcinogenesis.Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathwayUp-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion.Cell-cell contact preserves cell viability via plakoglobin.Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon.Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin.Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system.Plakoglobin suppresses epithelial proliferation and hair growth in vivoDelta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland.Beyond cell adhesion: the role of armadillo proteins in the heartPlakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.Desmosomes: new perpetrators in tumour suppressionEpstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch.Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormoneArmc5 deletion causes developmental defects and compromises T-cell immune responses.Cell-cell junctional proteins in cardiovascular mechanotransduction.The sonic hedgehog-GLI1 signaling pathway in brain tumor development.Aryl hydrocarbon receptor negatively regulates expression of the plakoglobin gene (jup).Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells.γ-Catenin acts as a tumor suppressor through context-dependent mechanisms in colorectal cancer.
P2860
Q21296710-BAD9E93A-5E25-40D0-A91D-077CFABD0BAAQ22254145-9D885C29-BBC7-488A-B8F2-67115E219051Q24339041-21DB73F9-8150-4946-A6BC-E6D842C5228CQ24537740-369ED952-AEBB-4523-8114-857B64A408B2Q24597197-DBC23384-013A-4A3A-94F4-211C53612CBCQ24673777-73B42E4E-EBAB-4B23-844F-286C27DC4CB0Q24683009-F5DA2464-AA35-4518-BF02-48789D2F8EF7Q28143178-AD0424B3-0F8F-46A5-8FDB-8785AB0FDCFFQ28143992-51B67C12-3231-4642-8941-F022054A68DAQ28144433-B34AB21E-D6B9-445C-A73A-EF06D1953AE8Q28220621-08EBFC09-D4C0-42AC-985B-8A0DDEBFEAECQ28282874-A4C0431F-1C20-4557-9EE2-B2C2438BDE9EQ28943312-5B71B7D4-F8B2-4BBF-BFAC-8AD6B7A46F9EQ33833342-8B8E68CD-91E0-49DD-936F-35D43EC9E460Q33864266-86B9B544-B5B2-4248-881D-D486AB3D9921Q33936505-A3CF340E-AC10-4664-9200-804D892897CCQ34088774-3027A096-8EFC-4777-A899-9D3523A37519Q34128162-248244B8-72D8-4B81-8363-68C2999D21D2Q34246978-067D7DAF-9D65-43F3-9DC0-5125C6114E7AQ34459652-137E203C-43A0-4D4C-8ABF-D002360D73BEQ34758600-BC6BEBE4-94CA-4564-9FBA-48D10ED8DB7BQ35087817-03D7C048-39B5-48A8-9000-19BAA73A8F84Q35472984-682334A2-1199-4785-A0B0-1D5F23F554D4Q35594538-2C0F2BD5-3EFA-45E0-B938-5854CCD2A5B2Q35769582-6FF3E1CE-72F1-405D-888A-890115F4CAC5Q36143099-39240893-0BB0-4CCE-AA30-77F88972EC5BQ36275000-D97A8FE2-FC57-4206-B46B-00EFC7741FCAQ36328372-937EC0F8-DDB6-4314-BDE4-B0CAF8CEDE2DQ36360340-187A227D-97E7-4B84-95F9-AF26AA3B8997Q36429110-51B4AB93-D0D1-4C70-869D-626DC5906751Q36868797-A852CB01-C403-4372-BEFE-3048E4C84F4DQ37237903-973A9F93-E9B1-4170-8BAD-0AF933688647Q37408369-50849FA3-1CA8-4F2F-890E-D3F64D5BD5EEQ37589848-A0E74FAE-D886-48E6-9C09-15F5CB3012A2Q37642446-F0C23A18-F919-4D28-85D9-ED0F60960C2DQ37948017-11BF0169-D60E-40CD-BE7A-543F230D3C9BQ38044769-DFC4D935-8264-4E68-93A7-D24EA38070ACQ38315336-CE0D5B8A-83CB-448C-B5EE-63CD070AF5EBQ38347114-4E183295-B3FC-438D-B52E-318BD470D150Q38662271-284F9E3F-74AD-408E-A931-E59194816DD8
P2860
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.
@en
type
label
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.
@en
prefLabel
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.
@en
P2093
P2860
P356
P1476
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin
@en
P2093
S Yehuda-Levenberg
P2860
P304
P356
10.1083/JCB.133.1.199
P407
P50
P577
1996-04-01T00:00:00Z